4//SEC Filing
Eichenfield Lawrence 4
Accession 0001209191-22-033616
CIK 0001419041other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:09 PM ET
Size
5.8 KB
Accession
0001209191-22-033616
Insider Transaction Report
Form 4
Eichenfield Lawrence
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-01+25,000→ 25,000 totalExercise: $1.27Exp: 2032-06-01→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean June 1, 2022.
Documents
Issuer
Forte Biosciences, Inc.
CIK 0001419041
Entity typeother
Related Parties
1- filerCIK 0001814892
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:09 PM ET
- Size
- 5.8 KB